How Does the Patient Benefit from Clinical PET?
<p>Clinical molecular imaging by use of PET and PET/CT is increasingly important in routine oncological practice worldwide. A vast majority of clinical PET investigations are performed with [<sup>18</sup>F]-fluorodeoxyglucose (FDG), but there is a growing interest in novel molecula...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ivyspring International Publisher
2012-01-01
|
| Series: | Theranostics |
| Online Access: | http://www.thno.org/v02p0427.htm |